Recellularization of biological heart valves with human vascular cells: In vitro hemocompatibility assessment

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 88, Issue 1, 2009, Pages 130-138

  Schopka, Simon ^a   Schmid, Franz Xaver ^a   Hirt, Stephan ^a   Birnbaum, Dietrich E ^a   Schmid, Christof ^a   Lehle, Karla ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Cardiovascular tissue engineering; Decellularized bovine pericardium; Endothelial cells; Fibroblasts; Functional analysis; Hemocompatibility; Preseeding

Indexed keywords

ANTITHROMBOTIC PROPERTIES; BIOPROSTHESES; BLOOD COMPATIBILITIES; BOVINE PERICARDIUM; CARDIOVASCULAR BIOMATERIALS; CARDIOVASCULAR TISSUE ENGINEERING; CELL FUNCTIONS; CELLULAR FUNCTIONS; CELLULAR PROPERTIES; DECELLULARIZED; DECELLULARIZED BOVINE PERICARDIUM; ELECTRONIC MICROSCOPIES; ENDOTHELIALIZATION; FUNCTIONAL PROPERTIES; GLUTARALDEHYDE; HEART VALVES; HEMOCOMPATIBILITY; IMMUNOHISTOCHEMISTRY; IMPROVING PERFORMANCES; IN VITRO; INFLAMMATORY CELLS; INFLAMMATORY STIMULATIONS; PLATELET ADHESIONS; PRESEEDING; RECELLULARIZATION; SAPHENOUS VEINS; SURFACE COVERAGES; VASCULAR CELLS;

ADHESION; ALDEHYDES; BIOLOGICAL MATERIALS; BIOMATERIALS; BLOOD SUBSTITUTES; BLOOD VESSEL PROSTHESES; CELL CULTURE; ELECTRIC CONDUCTIVITY MEASUREMENT; FIBROBLASTS; PLATELETS; PROBABILITY DENSITY FUNCTION; SELF ASSEMBLY; TISSUE; TISSUE ENGINEERING;

ENDOTHELIAL CELLS;

BIOMATERIAL; INTERLEUKIN 6; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTICOAGULATION; ARTICLE; BIOASSAY; BIOPROSTHESIS; BLOOD COMPATIBILITY; CELL ADHESION; CELL FUNCTION; CELL PROLIFERATION; COW; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; FIBROBLAST; FUNCTIONAL ASSESSMENT; HEART VALVE; HEMODYNAMICS; HISTOCOMPATIBILITY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; NONHUMAN; SAPHENOUS VEIN; SCANNING ELECTRON MICROSCOPY; TISSUE ENGINEERING; VASCULAR TISSUE;

ANIMALS; BIOCOMPATIBLE MATERIALS; CATTLE; CELL ADHESION; CELL PROLIFERATION; ENDOTHELIAL CELLS; FIBROBLASTS; HEART VALVE PROSTHESIS; HEART VALVES; HUMANS; INTERLEUKIN-6; MICROSCOPY, ELECTRON, SCANNING; PERICARDIUM; TISSUE ENGINEERING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 57349096013     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31159     Document Type: Article

References (38)

1. Yacoub MH, Takkenberg JJ. Will heart valve tissue engineering change the world. Nat Clin Pract Cardiovasc Med 2005;2:60-61.
2. Emery RW, Krogh CC, Arom KV, Emery AM, Benyo-Albrecht K, Joyce LD, Nicoloff DM. The St. Jude Medical cardiac valve prostheses: A 25-year experience with single valve replacement. Ann Thorac Surg 2005;79:776-782.
3. Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994;89:635-641.
4. Schoen FJ, Levy RJ. Tissue heart valves: Current challenges and future research perspectives. J Biomed Mater Res 1999;47:439-465.
5. Simon P, Kasimir MT, Seebacher G, Weigel G, Ullrich R, Salzer-Muhar U, Rieder E, Welner E. Early failure of tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg 2003;23:1002-1006.
6. Yacoub M, Rasmi NR, Sundt TM, Lund O, Boyland E, Radley-Smith R, Khagani A, Mitchell A. Fourteen year experience with homovital homografts for aortic valve replacement. J Thorac Cardiovasc Surg 1995;110:186-193.
7. Sodian R, Hoerstrup SP, Sperling JS, Daebritz S, Martin D, Moran A, Kim BS, Schoen FJ, Vacanti JP, Mayer JR Jr. Early in vivo experience with tissue engineered trileaflet heart valves. Circulation 2000;102(19, Suppl 3):III22-III29.
8. Schoen FJ, Levy RJ. Calcification of tissue heart valve substitutes: Progress toward understanding and prevention. Ann Thorac Surg 2005;79:1072-1080.
9. Trantina-Yates AE, Human P, Bracher M, Zilla P. Mitigation of bioprosthetic heart valve degeneration through biocompatibility: In vitro versus spontaneous endothelization. Biomaterials 2001;22:1837-1846.
10. Hoffman D, Gong G, Liao K, Macaluso F, Nikolic SD, Frater RW. Spontaneous host endothelial growth on bioprostheses. Influence of fixation. Circulation 1992;86(5 Suppl):II75-II79.
11. Bengtsson L, Ragnarson B, Haegerstrand A. Lining of viable and nonviable allogeneic and xenogeneic cardiovascular tissue with cultured adult human venous endothelium. J Thorac Surg 1993;106:434-443.
12. Fischlein T, Fasol R. In vitro endothelization of prosthetic heart valves. J Heart Valve Dis 1996;5:58-65.
13. Gulbins H, Goldemund A, Anderson I, Haas U, Uhlig A, Reichart B, Meiser B. Preseeding with autologous fibroblasts improves endothelization of glutaraldehyde-fixed porcine aortic valves. J Thorac Cardiovasc Surg 2003;125:592-601.
14. Lehle K, Haubner F, Munzel D, Birnbaum DE, Preuner JG. Development of a disease-specific model to evaluate endothelial dysfunction in patients with diabetes mellitus. Biochem Biophys Res Commun 2007;357:308-313.
15. Stevens JM. Platelet adhesion performed under static conditions. Methods Mol Biol 2004;272:145-151.
16. DeClerk L, Mertens A, Moens M, Stevens W. Use of fluorescent dyes in the determination of adherence of human leucocytes to endothelial cells and the effect of fluorochromes on cellular function. J Immunol Meth 1994;172:115-124.
17. Sozzani S, Vecchi A, Allavena P, Maulovani A. Chemotaxis and interaction with vascular or lymophatic endothelium. Methods Mol Biol 2004;239:1-16.
18. Gulbins H, Pritisanac A, Uhlig A, Goldemund A, Meiser BM, Reichert B, Daebritz S. Seeding of human endothelial cells on valve containing aortic mini roots: Development of a seeding device and procedure. Ann Thorac Surg 2005;79:2119-2126.
19. Mendelson K, Schoen FJ. Heart valve tissue engineering: concepts, approaches, progress, and challenges. Ann Biomed Eng 2006;34:1799-1819.
20. Grenier G, Remy-Zolghadri M, Guignard R, Bergeron F, Labbe R, Auger FA, Germain L. Isolation and culture of the three vascular cell types from a small vein biopsy sample. In Vitro Cell Dev Biol Anim 2003;39:131-139.
21. Dohmen PM, Lembcke A, Holinski S, Kivelitz D, Braun JP, Pruss A, Konertz W. Mid-term clinical results using a tissue-engineered pulmonary valve to reconstruct the right ventricular outflow tract during the Ross procedure. Ann Thorac Surg. 2007;84:729-736.
22. Grabenwoger M, Sider J, Fitzal F, Zelenka C, Winberger U, Grimm M, Moritz A, Böck P, Wolner E. Impact of glutaraldehyde on calcification of pericardial bioprosthetic heart valve material. Ann Thorac Surg 1996;62:772-777.
23. Fischlein T, Lehner G, Lante W, Reichhart B. Endothelialization of aldehyde-fixed cardiac valve bioprostheses. Transplant Proc 1992;24:2988.
24. Lehner G, Fischlein T, Barretton G, Murphy JG, Reichhart B. Endothelialized biological heart valve prostheses in the non-human primate model. Eur J Cardiothorac Surg 1997;11:498-504.
25. Leyh RG, Wilhelmi M, Rebe P, Ciboutari S, Haverich A, Mertsching H. Tissue engineering of viable pulmonary arteries for surgical correction of congenital heart defects. Ann Thorac Surg 2006;81:1466-1470.
26. Gulbins H, Pritisanac A, Petzold R, Goldemund A, Doser M, Dauner M, Meiser B, Reichart B, Daebritz S. A low-flow adaptation phase improves shear-stress resistance of artificially seeded endothelial cells. Thorac Cardiovasc Surg 2005;53:96-102.
27. Gulbins H, Pritisanac A, Pieper K, Goldemund A, Meiser BM, Reichart B, Daebritz S. Successful endothelialization of porcine glutaraldehyde-fixed aortic valves in a heterotopic sheep model. Ann Thorac Surg 2006;81:1472-1479.
28. Gulbins H, Goldemund A, Uhlig A, Pritisanac A, Meiser B, Reichart B. Implantation of an autologously endothelialized homograft. J Thorac Cardiovasc Surg 2003;126:890-891.
29. Remy-Zolghadri M, Laganiere J, Oligny JF, Germain L, Auger FA. Endothelium properties of a tissue engineered blood vessel for small-diameter vascular reconstruction. J Vasc Surg 2004;39:613-620.
30. Prasad Chennazhy K, Krishnan LK. Effect of passage number and matrix characteristics on differentiation of endothelial cells cultured for tissue engineering. Biomaterials 2005;26:5658-5667.
31. McGuigan A, Sefton M. The Influence of biomaterials on endothelial cell thrombogenicity. Biomaterials 2007;28:2547-2571.
32. Kasimir MT, Weigel G, Sharma J, Rieder E, Seebacher G, Wolner E, Simon P. The decellularized porcine heart valve matrix in tissue engineering: Platelet adhesion and activation. Thromb Haemost 2005;94:562-567.
33. Levi M, van der Poll T, Buller HR. Bidirectional relation between inflammation and coagulation. Circulation 2004;109:2698-2704.
34. Fann JI, Miller DC, Moore KA, Mitchell RS, Over PE, Stinson EB, Robbins RC, Reitz BA, Shumway NE. Twenty year experience with porcine bioprostheses. Ann Thorac Surg 1996;62:1301-1311.
35. Human P, Zilla P. Characterization of the immune response to valve bioprostheses and its role in primary tissue failure. Ann Thorac Surg 2001;71(5 Suppl):385-388.
36. Kim SS, Lim SH, Cho SW, Gwak SJ, Hong YS, Chang BC, Park MH, Song KW, Choi CY, Kim BS. Tissue engineering of heart valves by recellularization of glutaraldehyde-fixed porcine valves using bone marrow-derived cells. Exp Mol Med 2006;38:273-283.
37. Fang NT, Xie SZ, Wang SM, Gao HY, Wu CG, Pan LF. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells. Chin Med J (Engl) 2007;120:696-702.
38. Schmidt D, Achermann J, Odermatt B, Breymann C, Mol A, Genoni M, Zund G, Hoerstrup SP. Prenatally fabricated autologous human living heart valves based on amniotic fluid derived progenitor cells as single cell source. Circulation 2007;116(11 Suppl):I64-I70.